Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences Read More > October 17, 2020
Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study Read More > October 17, 2020
Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice Read More > October 15, 2020
Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice Read More > October 15, 2020
Psychedelic Psychiatry: Preparing for Novel Treatments Involving Altered States of Consciousness Read More > October 14, 2020
The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD Read More > October 14, 2020
The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence Read More > October 11, 2020
Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans Read More > October 8, 2020
Polypharmacology or “Pharmacological Promiscuity” In Psychedelic Research: What Are We Missing? Read More > October 6, 2020
